Phase 3 Joint Infection Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Infection Prophylaxis in Total Joint Replacement
Periprosthetic Joint Infection
Hamilton Health Sciences Corporation21,006 enrolled1 locationNCT06126614
Recruiting
Phase 2Phase 3
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
Prosthetic joint infection
Peptilogics240 enrolled9 locationsNCT07214311
Recruiting
Phase 2Phase 3
Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.
Antibiotic Resistant InfectionOsteoarthritis, HipProsthetic joint infection+1 more
University Hospital, Linkoeping1,100 enrolled1 locationNCT05169229